Newmed Energy upgraded to Equal Weight from Underweight at Barclays

Barclays upgraded Newmed Energy (DKDRF) to Equal Weight from Underweight with a price target of ILS 14.20, up from ILS 11. Israeli companies navigated 2024 with “remarkable strength,” the analyst tells investors in a research note. Looking ahead, the firm sees most upside potential across banks, insurance and real estate. Inline with its relative rating approach Barclays adjusted ratings into 2025.